Mechanisms of Cu-binding factors to promote myogenic gene expression
铜结合因子促进生肌基因表达的机制
基本信息
- 批准号:10618921
- 负责人:
- 金额:$ 36.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAtaxiaBindingBinding SitesBiochemicalBiochemical ReactionBiologyCardiacCategoriesCell Differentiation processCell LineageCell NucleusCell ProliferationCell physiologyCellsCellular StressChIP-seqChromatinChromatin StructureCoenzymesComplexCopperCoupledCulture MediaDataDeficiency DiseasesDevelopmentDevelopmental ProcessDifferentiation AntigensDiseaseDystoniaEnzymesExcretory functionFailureFamilyGene ActivationGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomic DNAGrowthHealthHepatolenticular DegenerationHomeostasisHumanHydroxyl RadicalHypertrophic CardiomyopathyImmunoprecipitationImpairmentIonsKnock-outKnowledgeLifeLocationMass Spectrum AnalysisMenkes Kinky Hair SyndromeMetabolismMetalsMitochondriaModelingModificationMolecularMolecular ChaperonesMusMuscleMuscle DevelopmentMuscle hypotoniaMutationMyoblastsMyogeninMyopathyNeurologicNeutropeniaOrganPathologicPathologyPatientsPeptide Sequence DeterminationPeripheral Nervous System DiseasesPhenotypePlayProliferatingProliferation MarkerPropertyProteinsRegulationRoleSkeletal MuscleSpecific qualifier valueStudy modelsTechniquesTestingTimeTissue DifferentiationTissue-Specific Gene ExpressionTissuesTrace ElementsTrace metalTranscriptional RegulationWestern Blottingabsorptioncofactorexpectationexperimental studygenomic locusin vivoiron absorptionknock-downmouse modelmyogenesisnovelposttranscriptionalpreventprogramspromoterrecruitsatellite cellskeletal muscle differentiationtranscription factortranscriptome sequencing
项目摘要
PROJECT SUMMARY
Cell development and differentiation require lineage specific mechanisms by which cells initiate programs
of gene expression. In normal conditions, lineage determination involves activation of genes that are
transcriptionally silent by specific transcription factors, chromatin remodelers, coactivators, and other lineage
specific molecules. Skeletal muscle differentiation is an excellent model for studying fundamental principles of
tissue-specific gene expression and differentiation as there is a significant understanding of mechanisms
controlling myogenic-specific gene expression. However, emerging evidence shows a novel category of
Copper (Cu)-binding factors that may have a previously unappreciated direct impact in the regulation of
myoblast proliferation and differentiation.
Cu is an essential trace metal that serves as a catalytic co-factor for a wide variety of enzymatic reactions
that play critical roles in life. Cu deficiency and overload leads to pathophysiological conditions including
Menkes and Wilson’s diseases, neutropenia, impaired iron absorption, peripheral neuropathy, mitochondrial
deficiencies and hypertrophic cardiomyopathy. Therefore, the mechanisms for Cu distribution and usage in
different tissues and organs, as well as the consequences due to dysregulated Cu acquisition, are important to
human health. Limited information is available regarding Cu and Cu-binding factors and their mechanisms of
action in myogenesis and most developmental processes. We propose to elucidate novel mechanisms of gene
regulation that drive muscle differentiation and development and that are dependent on copper and Cu-binding
transcription factors. We propose integrative studies that combine diverse molecular, biochemical and
spectroscopic techniques to characterize novel molecular mechanisms by which Cu-binding factors regulate
myogenic differentiation. We propose a novel model where Cu controls myogenesis by activating Cu-TFs that
may act synchronously, either by acting on different promoters at the same time or by acting sequentially at
different stages of differentiation, or both. Our experiments will identify new components and mechanisms for
mammalian Cu-binding factors in the regulation of lineage-specific gene expression. Our studies also will
establish a basis for understanding muscular diseases related to aberrant Cu biology using well-characterized
mouse models for Menkes and Wilson’s diseases. Understanding the molecular mechanisms that drive lineage
specific gene expression dependent on Cu will greatly advance our knowledge of several Cu-related diseases.
项目摘要
细胞发育和分化需要谱系特定机制,细胞启动程序
基因表达。在正常情况下,谱系测定涉及激活的基因
通过特定的转录因子,染色质远方,共激活因子和其他谱系在转录上保持沉默
特定分子。骨骼肌分化是研究的绝佳模型
组织特异性基因表达和分化,因为对机制有重大理解
控制肌源特异性基因表达。但是,新兴的证据显示了一个新颖的类别
铜(CU)结合因素可能在调节中具有先前未鉴定的直接影响
肌细胞增殖和分化。
Cu是一种必需的痕量金属,可作为多种酶促反应的催化co因子
那在生活中扮演关键的角色。 CU缺乏和超负荷会导致病理生理状况
Menkes和Wilson的疾病,中性rop虫,滥用铁受损,周围神经病,线粒体
缺乏症和肥厚性心肌病。因此,Cu分布和使用的机制
不同的组织和器官以及由于铜的失调而引起的后果对
人类健康。有关CU和CU结合因素及其机制的信息有限
在肌发生和大多数发育过程中的作用。我们建议阐明基因的新机制
驱动肌肉分化和发育的调节,并取决于铜和铜结合
转录因子。我们提出的综合研究结合了潜水者的分子,生化和
光谱技术来表征新型分子机制,通过这种机制来调节Cu结合因子
肌源分化。我们提出了一个新型模型,其中Cu通过激活Cu-TF来控制肌发生
可以同时行动,可以同时行动,或者通过在
分化的不同阶段,或两者兼而有之。我们的实验将确定新组件和机制
哺乳动物Cu结合因子在谱系特异性基因表达调节中。我们的研究也将
建立一个理解与异常CU生物学相关的肌肉疾病的基础
Menkes和Wilson疾病的鼠标模型。了解驱动谱系的分子机制
取决于CU的特定基因表达将大大提高我们对几种与CU相关疾病的了解。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential requirements for different subfamilies of the mammalian SWI/SNF chromatin remodeling enzymes in myoblast cell cycle progression and expression of the Pax7 regulator.
- DOI:10.1016/j.bbagrm.2022.194801
- 发表时间:2022-03
- 期刊:
- 影响因子:0
- 作者:Padilla-Benavides T;Olea-Flores M;Nshanji Y;Maung MT;Syed SA;Imbalzano AN
- 通讯作者:Imbalzano AN
The Oncopig as an Emerging Model to Investigate Copper Regulation in Cancer.
- DOI:10.3390/ijms232214012
- 发表时间:2022-11-13
- 期刊:
- 影响因子:5.6
- 作者:
- 通讯作者:
Differential Contributions of mSWI/SNF Chromatin Remodeler Sub-Families to Myoblast Differentiation.
- DOI:10.3390/ijms241411256
- 发表时间:2023-07-09
- 期刊:
- 影响因子:5.6
- 作者:
- 通讯作者:
ZIP11 Regulates Nuclear Zinc Homeostasis in HeLa Cells and Is Required for Proliferation and Establishment of the Carcinogenic Phenotype.
- DOI:10.3389/fcell.2022.895433
- 发表时间:2022
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresita Del Nino Jesus Padilla-Benavides其他文献
Teresita Del Nino Jesus Padilla-Benavides的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresita Del Nino Jesus Padilla-Benavides', 18)}}的其他基金
Mechanisms of Cu-binding factors to promote myogenic gene expression
铜结合因子促进生肌基因表达的机制
- 批准号:
10456324 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
Mechanisms of Cu-binding factors to promote myogenic gene expression
铜结合因子促进生肌基因表达的机制
- 批准号:
10209843 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
相似国自然基金
改良MitoQ用于常染色体隐性共济失调2型的治疗作用及机制研究
- 批准号:82301667
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
特异性短肽通过自噬降解脊髓小脑性共济失调3型突变蛋白的作用及机制研究
- 批准号:82371879
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
COX20缺陷致线粒体功能障碍激活cGAS-STING通路参与遗传性共济失调发病的机制研究
- 批准号:82302088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ATM 为胰岛素调节代谢灵活性关键介质和此特性在共济失调发病机制中的作用
- 批准号:32300643
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脊髓小脑共济失调36型相关DNA和RNA六核苷酸重复序列的结构与功能研究
- 批准号:22374132
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
相似海外基金
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Regulation of paraspeckles by STAU1 in neurodegenerative disease
STAU1 在神经退行性疾病中对 paraspeckles 的调节
- 批准号:
10668027 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Deciphering a novel kinase function for adck2 in the heart
破译心脏中 adck2 的新激酶功能
- 批准号:
10664070 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Investigation on Ataxin2 and Matrin3 in neurodegenerative disease
Ataxin2 和 Matrin3 在神经退行性疾病中的研究
- 批准号:
10668022 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Development of a splicing modulator compound for familial dysautonomia
开发用于家族性自主神经功能障碍的剪接调节剂化合物
- 批准号:
10680719 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别: